SyntekaBio, Inc. (KOSDAQ:226330)

SyntekaBio Statistics

Total Valuation

SyntekaBio has a market cap or net worth of KRW 67.37 billion. The enterprise value is 78.13 billion.

Market Cap	67.37B
Enterprise Value	78.13B

Important Dates

The last earnings date was Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

SyntekaBio has 15.26 million shares outstanding. The number of shares has increased by 0.06% in one year.

Current Share Class	15.26M
Shares Outstanding	15.26M
Shares Change (YoY)	+0.06%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	17.18%
Owned by Institutions (%)	0.03%
Float	12.64M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	37.77
PB Ratio	5.66
P/TBV Ratio	5.86
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-4.43
EV / Sales	43.81
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-7.20

Financial Position

The company has a current ratio of 0.20, with a Debt / Equity ratio of 1.06.

Current Ratio	0.20
Quick Ratio	0.12
Debt / Equity	1.06
Debt / EBITDA	n/a
Debt / FCF	-1.17
Interest Coverage	-4.40

Financial Efficiency

Return on equity (ROE) is -86.04% and return on invested capital (ROIC) is -24.17%.

Return on Equity (ROE)	-86.04%
Return on Assets (ROA)	-17.98%
Return on Invested Capital (ROIC)	-24.17%
Return on Capital Employed (ROCE)	-82.47%
Revenue Per Employee	34.30M
Profits Per Employee	-339.03M
Employee Count	n/a
Asset Turnover	0.04
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -25.55% in the last 52 weeks. The beta is 0.71, so SyntekaBio's price volatility has been lower than the market average.

Beta (5Y)	0.71
52-Week Price Change	-25.55%
50-Day Moving Average	4,466.20
200-Day Moving Average	6,287.00
Relative Strength Index (RSI)	44.41
Average Volume (20 Days)	956,050

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SyntekaBio had revenue of KRW 1.78 billion and -17.63 billion in losses. Loss per share was -1,155.39.

Revenue	1.78B
Gross Profit	1.78B
Operating Income	-11.85B
Pretax Income	-17.63B
Net Income	-17.63B
EBITDA	-9.78B
EBIT	-11.85B
Loss Per Share	-1,155.39

Balance Sheet

The company has 1.89 billion in cash and 12.65 billion in debt, giving a net cash position of -10.76 billion or -705.40 per share.

Cash & Cash Equivalents	1.89B
Total Debt	12.65B
Net Cash	-10.76B
Net Cash Per Share	-705.40
Equity (Book Value)	11.90B
Book Value Per Share	779.76
Working Capital	-15.30B

Cash Flow

In the last 12 months, operating cash flow was -10.80 billion and capital expenditures -47.71 million, giving a free cash flow of -10.85 billion.

Operating Cash Flow	-10.80B
Capital Expenditures	-47.71M
Free Cash Flow	-10.85B
FCF Per Share	-710.88

Margins

Gross Margin	99.68%
Operating Margin	-664.20%
Pretax Margin	-988.55%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SyntekaBio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.06%
Shareholder Yield	-0.06%
Earnings Yield	-26.17%
FCF Yield	-16.10%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SyntekaBio has an Altman Z-Score of -2.66 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.66
Piotroski F-Score	3